1,242
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Should anti-mesothelin therapies be explored in lung cancer?

Pages 677-679 | Received 15 Apr 2016, Accepted 18 May 2016, Published online: 31 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pranav Murthy, Chigozirim N. Ekeke, Kira L. Russell, Samuel C. Butler, Yue Wang, James D. Luketich, Adam C. Soloff, Rajeev Dhupar & Michael T. Lotze. (2019) Making cold malignant pleural effusions hot: driving novel immunotherapies. OncoImmunology 8:4.
Read now

Articles from other publishers (2)

Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, Ana Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo, Sergio Piñeiro-Hermida, Pablo Ramos, Juan José Lasarte, Ruth Vera, Grazyna Kochan & David Escors. (2022) CAR-T Cells for the Treatment of Lung Cancer. Life 12:4, pages 561.
Crossref
Christopher Montemagno, Shamir Cassim, Jacques Pouyssegur, Alexis Broisat & Gilles Pagès. (2020) From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 21:11, pages 4067.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.